Table 4. Family history and breast cancer hormone receptor status by age at diagnosis.
ER−&PR− vs. ER+/PR+ | ER− vs. ER+ | PR− vs. PR+ | |||||||
N of | N of | N of | |||||||
ER+/PR+ tumors | ER+ tumors | PR+ tumors | |||||||
/ER−&PR− tumors1 | OR (95% CI)2 | P 2 | /ER− tumors1 | OR (95% CI)2 | P 2 | /PR− tumors1 | OR (95% CI)2 | P 2 | |
Among <50 years old | |||||||||
Family history | |||||||||
o | 98/19 | 1.00 | 97/22 | 1.00 | 74/35 | 1.00 | |||
Yes | 40/21 | 2.79 (1.34–5.81) | 0.006 | 39/23 | 2.66 (1.32–5.39) | 0.006 | 36/24 | 1.40 (0.72–2.72) | 0.32 |
Among 50+ years old | |||||||||
Family history | |||||||||
No | 315/88 | 1.00 | 310/98 | 1.00 | 228/153 | 1.00 | |||
Yes | 51/13 | 0.91 (0.48–1.76) | 0.79 | 50/15 | 0.95 (0.51–1.76) | 0.87 | 38/20 | 0.79 (0.44–1.40) | 0.42 |
Subjects with missing information of ER, PR, or family history were removed from analyses.
Results were estimated from case-only logistic regressions with adjustment for age at diagnosis.